Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.913693
Abstract: The amyloid hypothesis for the pathogenesis of Alzheimer’s disease (AD) is widely accepted. Last year, the US Food and Drug Administration considered amyloid-β peptide (Aβ) as a surrogate biomarker and approved an anti-Aβ antibody, aducanumab,…
read more here.
Keywords:
pathogenesis alzheimer;
hypothesis;
alzheimer disease;
hypothesis pathogenesis ... See more keywords